Andrew Harkin

Prof. Andrew Harkin

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
WBWouter Beumer
Wouter Beumer
SGSinead M. Gibney
Sinead M. Gibney
RDRoosmarijn C. Drexhage
Roosmarijn C. Drexhage
LPLorena Pont-Lezica
Lorena Pont-Lezica
JDJanine Doorduin
Janine Doorduin
HDHemmo A Drexhage
Hemmo A Drexhage
Review on the key role for activated microglia and monocytes in the pathogenesis of bipolar disorder and schizophrenia. This review describes a key role for mononuclear phagocytes in the pathogenesis of major psychiatric disorders. There is accumulating evidence for activation of microglia (histopathology and PET scans) and circulating monocytes (enhanced gene expression of immune genes, an overproduction of monocyte/macrophage-related cytokines) in patients with bipolar disorder, major depressive disorder, and schizophrenia. These data are strengthened by observations in animal models, such as the MIA models, the chronic stress models, and the NOD mouse model. In these animal models of depressive-, anxiety-, and schizophrenia-like behavior, similar activations of microglia and circulating monocytes can be found. These animal models also make in-depth pathogenic studies possible and show that microglia activation impacts neuronal development and function in brain areas congruent with the altered depressive and schizophrenia-like behaviors.

1 August 2008 in Neuroscience Letters
Verified
Journal Article
Closed access
TCThomas J. Connor
Thomas J. Connor
NSNeasa Starr
Neasa Starr
JOJoan B. O'Sullivan
Joan B. O'Sullivan
AHAndrew Harkin
Andrew Harkin

1 February 2013 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
SGSinead M. Gibney
Sinead M. Gibney
BMBarry McGuinness
Barry McGuinness
CPChristine Prendergast
Christine Prendergast
AHAndrew Harkin
Andrew Harkin
TCThomas J. Connor
Thomas J. Connor

1 May 1999 in European Journal of Pharmacology
Verified
Journal Article
Closed access
AHAndrew Harkin
Andrew Harkin
KBKaren H Bruce
Karen H Bruce
BCBrandy Craft
Brandy Craft
IPIan A Paul
Ian A Paul

2 March 2013 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
VGValentina Gigliucci
Valentina Gigliucci
GOGrainne O’dowd
Grainne O’dowd
SCSheena Casey
Sheena Casey
DEDanielle Egan
Danielle Egan
SGSinead Gibney
Sinead Gibney
AHAndrew Harkin
Andrew Harkin

8 March 2017 in Acta Neuropsychiatrica
Verified
Journal Article
Closed access
PDF file
ÁAÁine Abautret-Daly
Áine Abautret-Daly
EDElaine Dempsey
Elaine Dempsey
APAdolfo Parra-Blanco
Adolfo Parra-Blanco
CMCarlos Medina
Carlos Medina
AHAndrew Harkin
Andrew Harkin
Introduction: Inflammatory bowel disease (IBD) is a chronic relapsing and remitting disorder characterised by inflammation of the gastrointestinal tract. There is a growing consensus that IBD is associated with anxiety- and depression-related symptoms. Psychological symptoms appear to be more prevalent during active disease states with no difference in prevalence between Crohn’s disease and ulcerative colitis. Behavioural disturbances including anxiety- and depression-like symptoms have also been observed in animal models of IBD.Results: The likely mechanisms underlying the association are discussed with particular reference to communication between the gut and brain. The close bidirectional relationship known as the gut–brain axis includes neural, hormonal and immune communication links. Evidence is provided for a number of interacting factors including activation of the inflammatory response system in the brain, the hypothalamic–pituitary–adrenal axis, and brain areas implicated in altered behaviours, changes in blood brain barrier integrity, and an emerging role for gut microbiota and response to probiotics in IBD.Discussion: The impact of psychological stress in models of IBD remains somewhat conflicted, however, it is weighted in favour of stress or early stressful life events as risk factors in the development of IBD, stress-induced exacerbation of inflammation and relapse.Conclusion: It is recommended that patients with IBD be screened for psychological disturbance and treated accordingly as intervention can improve quality of life and may reduce relapse rates.